MedCare Technologies, Inc. Appoints Bernard Van Antwerp as Director of Marketing for RxSheets.com
OAK BROOK, Ill., Apr 5, 2000 (BUSINESS WIRE) -- MedCare Technologies, Inc.
(NASDAQ: MCAR) announced today that it has appointed Bernard Van Antwerp as
Director of Marketing of the Company's RxSheets.com. Mr. Van Antwerp will be
responsible for the overall marketing of the Company's innovative
business-to-business online web site, RxSheets.com.
Mr. Van Antwerp joins the company from G.D. Searle, Monsanto's attractive
pharmaceutical unit that recently merged with Pharmacia & Upjohn to form
Pharmacia Corp. Mr. Van Antwerp was most recently Associate Director of U.S.
Business Development and Planning. He has ten-plus years of experience in the
pharmaceutical industry. Mr. Van Antwerp has also served in numerous roles
throughout the pharmaceutical industry including sales, contracting, and
marketing. He has worked for such companies as, Allergan and Boehringer Mannheim
and served as product manager for the product Retavase. He holds an MBA in
Finance from Wayne State University.
"We are very pleased to have Bernard join our organization,"' said Jeff Aronin,
President and Chief Executive Officer. "His focus will be to continue the
progress that we have achieved thus far with our innovative online product and
to expand the existing offerings that RxSheets.com can provide to
pharmaceautical companies and physicians. Bernard has a very strong background
in the pharmaceutical industry and will be a valuable addition to the
RxSheets.com team."
"We believe our site will be a valuable link between busy physicians and
pharmaceutical companies. Our site will augment, expand, and increase the speed
of informing physicians of pharmaceutical products and offer them sampling
options. As a result, patients and pharmaceutical companies will benefit from
our success, " said Aronin. "Based on our research, major pharmaceutical
companies spend approximately 33 cents of every revenue dollar, or approximately
$45 billion, in marketing. We believe RxSheets.com will be able to participate
in and help to facilitate the aggressive advertising campaigns that
pharmaceutical companies are currently spending to reach physicians. I am
confident that the addition of Bernard will strengthen our ability to create and
deliver the tremendous value that we feel this unique product has to offer
pharmaceutical companies and physicians."
RxSheets.com (www.rxsheets.com) is a newly created business-to-business web
site, directed exclusively at the physician and pharmaceutical marketplace. Most
pharmaceutical companies offer physicians samples of their drugs as part of
their marketing promotions. A trial sample of a drug is often the most effective
way to get a doctor to use a pharmaceutical company's product. RxSheets.com
offers a wide array of focused information and services that will enable
physicians to more efficiently and effectively manage the sampling of
pharmaceutical drugs. The site also offers an array of other features that are
relevant to the pharmaceutical industry.
MedCare Technologies, Inc. is a healthcare technology service company that
focuses on under-served high growth markets. The Company began by developing the
MedCare Program, now the nation's leading conservative therapy for treating
urinary incontinence, a hidden health condition that, at approximately $26
billion, costs more than diabetes and bypass surgery combined.
This news release contains forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. Forward-looking statements include
statements concerning plans, objectives, goals, strategies, future events or
performance and underlying assumptions and other statements, which are other
than statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and service
demand and acceptance, changes in technology, changes in insurance
reimbursement, economic conditions, the impact of competition and pricing,
government regulation, and other risks defined in this document and in
statements filed from time to time with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and whether made
by or on behalf of the Company are expressly qualified by these cautionary
statements and any other cautionary statements which may accompany the
forward-looking statements. In addition, the Company disclaims any obligation to
update any forward-looking statements to reflect events or circumstances after
the date hereof.
Investor Awareness, Inc. is not a brokerage firm or securities dealer, so this
is not a solicitation to buy or sell securities, and does not purport to be a
complete analysis of MedCare Technologies, Inc. (NASDAQ: MCAR). The material
herein was provided by MedCare Technologies, Inc. and is for informational
purposes only. Investment in the Company's securities involves a high degree of
risk and should not be considered without first reading its most recent
financial statements. Investor Awareness, Inc. receives a fee from MedCare
Technologies, Inc for marketing services and its owners/employees may from time
to time purchase, sell, or have a position in the securities of MedCare
Technologies, Inc.
For more information contact Investor Awareness, Inc. at 847-945-2222 or visit
www.investorawareness.com or www.medcareonline.com. |
